Tumor pyruvate kinase M2:A promising molecular target of gastrointestinal cancer

被引：2
|
作者：
Chen Guo [1 ]
Guan Li [2 ]
Jianing Hou [2 ]
Xingming Deng [2 ]
Sheng Ao [2 ]
Zhuofei Li [2 ]
Guoqing Lyu [2 ]
机构：
[1] Department of Biology,Southern University of Science and Technology
[2] Department of Gastrointestinal Surgery,Peking University Shenzhen Hospital
来源：
Chinese Journal of Cancer Research | 2018年 / 30卷 / 06期
关键词：
PKM2(pyruvate kinase M2); metabolic reprogramming; gene transcription; gastrointestinal cancer; therapy targets;
D O I：
暂无
中图分类号：
R735 [消化系肿瘤];
学科分类号：
摘要：
Gastrointestinal(GI) cancer is one of the most common causes of cancer-related deaths worldwide.Tumor markers are valuable in detecting post-surgical recurrence or in monitoring response to chemotherapy.Pyruvate kinase isoform M2(PKM2),a glycolytic enzyme catalyzing conversion of phosphoenolpyruvate(PEP) to pyruvate,confers a growth advantage to the tumor cells and enables them to adapt to the tumor microenvironment.In this review,we have summarized current research on the expression and regulation of PKM2 in tumor cells,and its potential role in GI carcinogenesis and progression.Furthermore,we have also discussed the potential of PKM2 as a diagnostic and screening marker,and a therapeutic target in GI cancer.
引用
收藏
页码：669 / 676
页数：8
相关论文
共 50 条
  • [41] Tumor M2-pyruvate kinase: A promising tumor marker in the diagnosis of gastro-intestinal cancer
    Hardt, PD
    Ngoumou, BK
    Rupp, J
    Schnell-Kretschmer, H
    Kloer, HU
    ANTICANCER RESEARCH, 2000, 20 (6D) : 4965 - 4968
  • [42] Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review
    Ewald, N
    Toepler, M
    Akinci, A
    Kloer, HU
    Bretzel, RG
    Hardt, PD
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2005, 43 (12): : 1313 - 1317
  • [43] Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells
    Kim, Dong Joon
    Park, Young Soo
    Kang, Min Gu
    You, Yeon-Mi
    Jung, Yuri
    Koo, Han
    Kim, Jung-Ae
    Kim, Mi-Ju
    Hong, Seung-Mo
    Lee, Kyong Bun
    Jang, Ja-June
    Park, Kyung Chan
    Yeom, Young Ii
    EXPERIMENTAL CELL RESEARCH, 2015, 336 (01) : 119 - 129
  • [44] Role of Pyruvate kinase M2 deficiency in cancer stemness property
    Sun, Kuang-Hui
    Sun, Wan-Hsuan
    Fang, Hsueh-Jou
    Peng, Ta-Jung
    CANCER SCIENCE, 2025, 116 : 464 - 464
  • [45] Synthesis of a Sulfonamide Pyruvate Kinase M2 Activator for Cancer Therapy
    Zhang, Qun-Zheng
    Zhang, Dian
    Huang, Fei
    Ke, Cong-Yu
    Pan, Qing
    Zhang, Xun-Li
    CURRENT ORGANIC SYNTHESIS, 2017, 14 (04) : 578 - 581
  • [46] Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer
    Prakasam, Gopinath
    Iqbal, Mohammad Askandar
    Bamezai, Rameshwar N. K.
    Mazurek, Sybille
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [47] The Multifarious Functions of Pyruvate Kinase M2 in Oral Cancer Cells
    Kurihara-Shimomura, Miyako
    Sasahira, Tomonori
    Nakashima, Chie
    Kuniyasu, Hiroki
    Shimomura, Hiroyuki
    Kirita, Tadaaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [48] Knockdown of pyruvate kinase M2 suppresses bladder cancer progression
    Luo, Guang-Cheng
    Xu, Ran
    Zhang, Xi
    Xu, Lin
    Zhao, Xiao-Kun
    Wang, Xin-Jun
    ONCOLOGIE, 2023, 25 (01) : 37 - 50
  • [49] Characterization of Pyruvate Kinase M2 in the Retina
    Rajala, Raju V. S.
    Rajala, Ammaji
    Wang, Yuhong
    Anderson, Robert E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [50] Enzyme Kinetic Assay to Measure the Activity of Tumor M2 Pyruvate Kinase in Breast Cancer Patients
    Guan, Mingxiu
    Tong, Yingna
    Liu, Xiaobin
    Dong, Dong
    Zhou, Yunli
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2017, 47 (06): : 676 - 686
12345